Synmosa Biopharma (ROCO:4114) EPS (Basic) : NT$1.67 (TTM As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is Synmosa Biopharma EPS (Basic)?

Synmosa Biopharma's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was NT$0.48. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$1.67.

Synmosa Biopharma's EPS (Diluted) for the three months ended in Mar. 2025 was NT$0.48. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$1.66.

Synmosa Biopharma's EPS without NRI for the three months ended in Mar. 2025 was NT$0.48. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 1.66.

During the past 12 months, Synmosa Biopharma's average EPS without NRIGrowth Rate was 3.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 28.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 44.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 36.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Synmosa Biopharma's highest 3-Year average EPS without NRI Growth Rate was 379.90% per year. The lowest was -68.40% per year. And the median was 16.20% per year.

Synmosa Biopharma EPS (Basic) Historical Data

The historical data trend for Synmosa Biopharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synmosa Biopharma EPS (Basic) Chart

Synmosa Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

1.80

0.76

2.03

1.45

1.62

Synmosa Biopharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.43	0.48	0.39	0.33	0.48

Synmosa Biopharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Synmosa Biopharma's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(684.683	-	0)	/	422.611
	=	1.62

Synmosa Biopharma's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(206.974	-	0)	/	434.247
	=	0.48

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.67

Synmosa Biopharma (ROCO:4114) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Synmosa Biopharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Synmosa Biopharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Synmosa Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synmosa Biopharma Corp (ROCO:4114) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6, Gongye 1st Road, Hukou Township, Hsinchu County, Hsinchu, TWN

Website

https://www.synmosa.com.tw

Synmosa Biopharma Corp is engaged in the research and development, manufacturing, marketing, and distribution of pharmaceutical products, medical devices, cosmetics, animal drugs, chemical food additives, and beverages. It is also involved in manufacturing and sales, and environmental drugs wholesale (retail), as well as the import and export of related businesses. The company provides prescription, OTC medicines, and healthcare products under its Synmosa trademark. The reporting segments of the company are; the Generic Drugs segment which derives key revenue, and the Active Pharmaceutical Ingredients segment.

Synmosa Biopharma Headlines

No Headlines